Khoshnevis Parviz MD is categorized under Gynecologists and OB GYNs in Rockingham, NC and active since 1997.
Khoshnevis Parviz MD was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Gynecologists and OB GYNs business, which does work in the B2C market, and is classified as a Gynecologists and OB GYNs, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Parviz Khoshnevis at the company’s single location by writing to 921 South Long Drive # 101, Rockingham, North Carolina NC 28379 or by phoning (910) 417-3850. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Khoshnevis Parviz MD |
| Contact Person: | Parviz Khoshnevis |
| Address: | 921 South Long Drive # 101, Rockingham, North Carolina 28379 |
| Phone Number: | (910) 417-3850 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1997 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Gynecologists and OB GYNs |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Khoshnevis Parviz MD was started in 1997 to provide professional Gynecologists and OB GYNs under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Parviz Khoshnevis for inquiries that concern Khoshnevis Parviz MD by calling the company number (910) 417-3850, as your correspondence is most welcome. Additionally, the physical location of the single location of Khoshnevis Parviz MD can be found at the coordinates 34.92988,-79.75107 as well as the street address 921 South Long Drive # 101 in Rockingham, North Carolina 28379.
For its online presence, you may visit Khoshnevis Parviz MD’s website at and engage with its social media outlets through on Twitter and on Facebook.